SAGE Oncotest™ Requisition Form Please enable JavaScript in your browser to complete this form.Please enable JavaScript in your browser to complete this form.Patient Information LayoutPatient Name *Date of Birth *Email *Gender *Phone Number *Diagnosis ICD10 *Test RequestedSAGE HT Oncotest™Ordering Physician LayoutPhysician Name *FirstLastPhone/FaxLayout (copy)InstitutionEmail *Layout (copy)Lab Reference #Physician’s NPIAddressAddress Line 1Address Line 2CityAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingStateZip CodeBiopsy Sample Requisition I am hereby requesting for my patient a fresh biopsy sample obtained duringthe upcoming surgery,the upcoming diagnostic procedure,* ora procedure conducted for the sole purpose of obtaining this biopsy, andto be sent to SageMedic Corp to perform the SAGE HT Oncotest™. Please provide a fresh sterile sample using the SAGE shipment kit, activate the cooling mechanism, and use the FedEx return label for overnight shipment. *Note that a core needle biopsy must have at least two 12 gauge needle cores of at least 1 cm of malignant tissue. Patient Consent I have explained to the patient the purpose, risks, and benefits of the test being ordered for clinical care and/or study participation and I have obtained patient informed consent for SageMedic to (a) perform the test described in this form, (b) obtain, receive, and release, test results, and any corresponding medical information as necessary; (c) and retain and use samples and information obtained, including the test results, for an indefinite period of time. Indication The SAGE HT Oncotest™ is a cytometric profiling and drug resistance test of the patient’s fresh biopsy and the purpose is to obtain additional information for providing standard of care according to applicable guidelines, specifically for the consideration of the upcoming Indicationsneo-adjuvant therapyadjuvant therapy1st line2nd line3rd line therapyOther reasonSingle Line TextPayment The SAGE HT Oncotest™ does not have a reimbursement code, so costs will be covered by one of the options below.The patient signed a purchase order and agreed to pay SAGE for the SAGE HT Oncotest™.The patient signed up for a pilot study and agreed to pay SAGE for participation and the SAGE HT Oncotest™.The cost for the SAGE HT Oncotest™ is waived, e.g. the patient is a physician or for a limited trial period.Patient History and Drug Panel Form LayoutPatient Name *FirstLastDiagnosed onDate of BirthPrimary Tumor LocationBreastBrainColonKidneyLungMelanomaOvaryPancreasOtherSingle Line Text (copy)Current StagingStage 0Stage IStage IIStage IIIStage IVHistology Type (if known)AdenoSquamousSmall cellSerousEpithelialLuminal ALuminal BOtherSingle Line Text (copy) (copy)Biomarker, including Genomic Mutations (if known)PD-L1 pos.MSI highKi67 highBRCA pos.EGFR pos.HER2 pos.ER/PR pos.Triple neg.BRAFKRASNRASALKRETMETROS1PIK3CANTKROtherSingle Line Text (copy) (copy) (copy)Past and Current Surgical, Radiation, and/or Systemic TreatmentsSurgeryRadiationAdjuvantNeo-adjuvant1st line2nd line ChemoParagraph TextTumor Specific Drug Panels or Individually Selected Drugs*Basic PanelAdvanced PanelPremium Panel*See attached sheet of tumor specific panels. Note that all in-vitro assays have false positive and false negative results and can never be perfect predictors of clinical responses. Thus, the SAGE Oncotest™ should be used to assist the clinician in deciding between therapies which, in the absence of these results, are all considered to be equally acceptable: “Going beyond standard of care within standard of care!” In special cases, e.g. exhaustion of standard therapy, a specific drugs or a set of drugs may be ordered4 Drug Panel6 Drug Panel8 Drug Panel with Targeted TherapiesCheckboxesCisplatinCarboplatinOxaliplatinPaclitaxelCyclophosphamideIfosfamideTemozolomideDocetaxelGemcitabine5-FUMethotrexatePemetrexedDoxorubicinEpirubicinBleomycinMitomycin-CTopotecanIrinotecanEtoposideVinorelbineAfitinibNiraparibOlaparibRucaparibThe undersigned represents that he/she is a licensed medical professional authorized to order patient testing, acknowledges that the patient has been supplied with all relevant information regarding the SAGE Oncotest™, including risks and benefits, and that the patient has given consent for the test to be performed. I request laboratory interpretation of these results and confirm that this may be used in the medical management and treatment decisions for this patient SignatureClear SignatureDateSubmit